Pregled bibliografske jedinice broj: 1185656
Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response
Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response // Molecules, 27 (2022), 5; 1468-1495 doi:10.3390/molecules27051468 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 1185656 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Oxidative Stress and Cancer Heterogeneity
Orchestrate NRF2 Roles Relevant for Therapy Response
Autori
Gall Trošelj, Koraljka ; Tomljanović, Marko ; Jaganjac, Morana ; Matijević Glavan, Tanja ; Čipak Gašparović, Ana ; Milković , Lidija ; Borović Šunjić, Suzana ; Buttari, Brigitta ; Profumo, Elisabetta ; Saha, Sarmistha ; Saso, Luciano ; Žarković, Neven
Izvornik
Molecules (1420-3049) 27
(2022), 5;
1468-1495
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
4-hydroxynonenal ; therapy resistance ; cancer stem cells ; tumor associated macrophages (TAMs) ; tumor associated neutrophils (TANs) ; polarization ; NFE2L2 promoter ; KEAP-1 ; micro RNA
Sažetak
Oxidative stress and its end-products, such as 4- hydroxynonenal (HNE), initiate activation of the Nuclear Factor Erythroid 2-Related Factor 2 (NRF2)/Kelch Like ECH Associated Protein 1 (KEAP1) signaling pathway that plays a crucial role in the maintenance of cellular redox homeostasis. However, an involvement of 4-HNE and NRF2 in processes associated with the initiation of cancer, its progression, and response to therapy includes numerous, highly complex events. They occur through interactions between cancer and stromal cells. These events are dependent on many cell-type specific features. They start with the extent of NRF2 binding to its cytoplasmic repressor, KEAP1, and extend to the permissiveness of chromatin for transcription of Antioxidant Response Element (ARE)- containing genes that are NRF2 targets. This review will explore epigenetic molecular mechanisms of NRF2 transcription through the specific molecular anatomy of its promoter. It will explain the role of NRF2 in cancer stem cells, with respect to cancer therapy resistance. Additionally, it also discusses NRF2 involvement at the cross-roads of communication between tumor associated inflammatory and stromal cells, which is also an important factor involved in the response to therapy.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
HRZZ-IP-2016-06-4404 - NRF2 na raskrižju epigenetičkog modeliranja, metabolizma i proliferacije stanice raka (CrossEMPATICNRF2) (Gall-Trošelj, Koraljka, HRZZ - 2016-06) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb
Profili:
Morana Jaganjac
(autor)
Koraljka Gall Trošelj
(autor)
Suzana Borović Šunjić
(autor)
Ana Čipak Gašparović
(autor)
Lidija Milković
(autor)
Tanja Matijević Glavan
(autor)
Marko Tomljanović
(autor)
Neven Žarković
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE